Advanced in Intestinal Pseudo-Obstruction

Hideo A. Baba

Kumamoto, JP 
Advanced in Intestinal Pseudo-Obstruction
Kumamoto, JP 
OverviewLocationsClinical Research

Overview

Hideo Baba practices in Kumamoto, Japan. Mr. Baba is rated as an Advanced expert by MediFind in the treatment of Intestinal Pseudo-Obstruction. His top areas of expertise are Colorectal Cancer, Esophageal Cancer, Stomach Cancer, Hepatectomy, and Pancreaticoduodenectomy.

His clinical research consists of co-authoring 1385 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 2 articles in the study of Intestinal Pseudo-Obstruction.

Gender
Male

Locations

Kumamoto, Japan
Other Locations
Saitama, Japan
Wako, 3510198, Japan
Tokyo, Japan
Honjo, 8608556, Japan
Chuo, Japan
Kumamachi, 8608556, Japan
Chuo, Japan
Nagasaki, Japan
Sasebo, Japan
Honjo, Japan
Niigata, Japan
Kumamoto, Japan
Yatsushiro, 8668660, Japan
Fukuoka, Japan

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Randomized, Double-Blind, Phase III Study Comparing FTD/TPI Therapy Versus Placebo in Patients Who Are Positive for Blood Circulating Tumor DNA After Curative Resection of Colorectal Cancer
A Randomized, Double-Blind, Phase III Study Comparing FTD/TPI Therapy Versus Placebo in Patients Who Are Positive for Blood Circulating Tumor DNA After Curative Resection of Colorectal Cancer
Enrollment Status: Unknown
Publish Date: November 18, 2022
Intervention Type: Drug
Study Drugs: Trifluridine, Tipiracil
Study Phase: Phase 3

1385 Total Publications

A subgroup of anaplastic thyroid carcinomas harbors MET alterations with potential therapeutic options.
A subgroup of anaplastic thyroid carcinomas harbors MET alterations with potential therapeutic options.
Journal: Pathology, research and practice
Published: May 14, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Baba's expertise for a condition
ConditionClose
View All 7 Elite Conditions
View All 8 Distinguished Conditions
View All 41 Advanced Conditions
View All 127 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile